Close Menu

NEW YORK – The GenomeWeb Index fell 3 percent in February, ending the winning streak it had been on for the past several months.

The index underperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which rose 3 percent, rose 1 percent, and fell 2 percent, respectively, in February. Individual stock performances in the GenomeWeb Index were fairly balanced last month, as 18 of the 37 stocks saw gains and 19 saw losses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.